Kestra Advisory Services LLC Has $628,000 Stake in SPDR S&P Pharmaceuticals ETF $XPH

Kestra Advisory Services LLC boosted its holdings in SPDR S&P Pharmaceuticals ETF (NYSEARCA:XPH) by 329.7% in the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 11,603 shares of the company’s stock after purchasing an additional 8,903 shares during the quarter. Kestra Advisory Services LLC owned about 0.19% of SPDR S&P Pharmaceuticals ETF worth $628,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also bought and sold shares of the business. Turtle Creek Wealth Advisors LLC bought a new position in shares of SPDR S&P Pharmaceuticals ETF in the first quarter valued at $26,000. Private Advisor Group LLC bought a new stake in shares of SPDR S&P Pharmaceuticals ETF during the first quarter worth about $3,017,000. SVB Wealth LLC raised its holdings in shares of SPDR S&P Pharmaceuticals ETF by 5.1% in the 1st quarter. SVB Wealth LLC now owns 45,668 shares of the company’s stock worth $2,470,000 after acquiring an additional 2,218 shares during the last quarter. Rockefeller Capital Management L.P. raised its holdings in shares of SPDR S&P Pharmaceuticals ETF by 3.2% in the 4th quarter. Rockefeller Capital Management L.P. now owns 20,043 shares of the company’s stock worth $1,123,000 after acquiring an additional 627 shares during the last quarter. Finally, First Citizens Bank & Trust Co. lifted its position in SPDR S&P Pharmaceuticals ETF by 2.5% in the 4th quarter. First Citizens Bank & Trust Co. now owns 186,004 shares of the company’s stock valued at $10,418,000 after acquiring an additional 4,575 shares in the last quarter.

SPDR S&P Pharmaceuticals ETF Stock Performance

Shares of XPH opened at $67.95 on Friday. SPDR S&P Pharmaceuticals ETF has a 52 week low of $40.80 and a 52 week high of $70.15. The stock has a 50 day moving average price of $62.65 and a two-hundred day moving average price of $58.52. The firm has a market capitalization of $472.25 million, a P/E ratio of 14.28 and a beta of 0.58.

About SPDR S&P Pharmaceuticals ETF

SPDR S&P Pharmaceuticals ETF (the Fund) seeks to replicate as closely as possible the total return performance of the S&P Pharmaceuticals Select Industry Index. The S&P Pharmaceuticals Select Industry Index represents the pharmaceuticals sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.